BenevolentAI lays off 30% of staff, exits US site as funding gap looms

BenevolentAI lays off 30% of staff, exits US site as funding gap looms

Source: 
Fierce Biotech
snippet: 

The cuts keep coming at BenevolentAI. Eleven months after restructuring, the AI-enabled drug developer is pulling another pivot, axing plans to launch software products, laying off another 30% of staff and closing its U.S. office.